Search    Show all

1 People found

filters applied:


1 / 1

EMBO Member

Alberto Bardelli

Istituto Firc di Oncologia Molecolare, Milano | Italy

EMBO 2017

Precision oncology, cancer genomics

When metastatic cancers are challenged with targeted agents, almost invariably a subset of cells insensitive to the drug emerges. As a result targeted therapies are often only transiently effective in patients. How can we overcome the near-certainty of disease recurrence following treatment with targeted agents? Addressing this question means considering as a target not 'only' individual oncogenes but also the evolving nature of human tumors.

Keywords: Colorectal cancer / genomics / resistance to therapy / liquid biopsies / cancer models

Subject area(s): Genomic & Computational Biology | Molecular Medicine | Signal Transduction